$VGAS
Verde Clean Fuels Inc Stock $vgas

$vgas Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000121390023040105 Filed on May 16, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022 Q1
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.230M		$279.9K
YoY Change	1411.31%
% of Gross Profit
Research & Development	$82.66K		$97.24K
YoY Change	-14.99%
% of Gross Profit
Depreciation & Amortization	$580.00	$0.00	$2.714K
YoY Change	-78.63%
% of Gross Profit
Operating Expenses	$82.66K	$1.310M	$279.9K
YoY Change	-70.47%	241.93%	13421.26%
Operating Profit	-$3.117M		-$1.425M
YoY Change	118.7%
Interest Expense	-$70.00K	$1.470M	$16.56K
YoY Change	-522.71%	-7910.84%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$3.120M	$170.0K	-$263.3K
YoY Change	1084.87%	-142.29%	12620.77%
Income Tax		$300.0K	$0.00
% Of Pretax Income		176.47%
Net Earnings	-$3.117M	-$130.0K	-$935.4K
YoY Change	233.24%	-67.66%	45154.28%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.09
Diluted Earnings Per Share	-$0.09	-$0.01	-$12.11K
COMMON SHARES
Basic Shares Outstanding	6.124M shares
Diluted Shares Outstanding	6.124M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$34.81M	$177.9M	$155.9K
YoY Change	22224.12%	35095.16%	270.47%
Cash & Equivalents	$34.81M	$128.0K	$558.7K
Short-Term Investments		$177.8M
Other Short-Term Assets	$1.700M	$0.00	$170.0K
YoY Change	900.0%	-100.0%	534.33%
Inventory
Prepaid Expenses	$1.571M	$6.667K
Receivables
Other Receivables
Total Short-Term Assets	$36.51M	$134.6K	$325.9K
YoY Change	11101.17%	-81.52%	373.12%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.834K	$7.414K
YoY Change
Goodwill
YoY Change
Intangibles		$1.925M
YoY Change
Long-Term Investments		$177.8M	$174.2M
YoY Change		2.05%
Other Assets	$1.925M	$1.925M
YoY Change
Total Long-Term Assets	$7.891M	$178.3M	$174.2M
YoY Change	-95.47%	2.34%	64827.61%
TOTAL ASSETS
Total Short-Term Assets	$36.51M	$134.6K	$325.9K
Total Long-Term Assets	$7.891M	$178.3M	$174.2M
Total Assets	$44.40M	$178.4M	$174.6M
YoY Change	-74.57%	1.99%	51661.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$242.8K	$2.857M	$790.8K
YoY Change	-69.3%
Accrued Expenses	$995.3K	$762.1K
YoY Change		215.47%
Deferred Revenue
YoY Change
Short-Term Debt	$420.0K	$2.000M	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$190.0K
YoY Change
Total Short-Term Liabilities	$2.338M	$7.418M	$118.7K
YoY Change	1869.37%	2970.78%	-62.79%
LONG-TERM LIABILITIES
Long-Term Debt	$5.270M	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.670M	$4.300M	$6.038M
YoY Change	-72.34%	-28.78%
Total Long-Term Liabilities	$6.942M	$1.384M	$6.038M
YoY Change	14.98%	-77.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.338M	$7.418M	$118.7K
Total Long-Term Liabilities	$6.942M	$1.384M	$6.038M
Total Liabilities	$9.280M	$11.73M	$6.156M
YoY Change	50.74%	86.82%	1829.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$21.75M	-$10.87M
YoY Change		96.05%
Common Stock	$936.00	$368.00
YoY Change		1836.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$12.17M	-$10.87M	-$6.481M
YoY Change
Total Liabilities & Shareholders Equity	$44.40M	$178.4M	$174.6M
YoY Change	-74.57%	1.99%	51661.9%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022 Q1
OPERATING ACTIVITIES
Net Income	-$3.117M	-$130.0K	-$935.4K
YoY Change	233.24%	-67.66%	45154.28%
Depreciation, Depletion And Amortization	$580.00	$0.00	$2.714K
YoY Change	-78.63%
Cash From Operating Activities	-$2.846M	-$260.0K	-$349.6K
YoY Change	714.11%	209.19%	1110.91%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		-$1.440M
YoY Change
Cash From Investing Activities		-$1.440M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$37.20M	1.820M
YoY Change		3540.0%
NET CHANGE
Cash From Operating Activities	-$2.846M	-260.0K	-349.6K
Cash From Investing Activities		-1.440M
Cash From Financing Activities	$37.20M	1.820M
Net Change In Cash	$34.35M	120.0K	$0.00
YoY Change		-452.01%	-100.0%
FREE CASH FLOW
Cash From Operating Activities	-$2.846M	-$260.0K	-$349.6K
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$2.846M	-$260.0K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-40743
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Verde Clean Fuels, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1863331
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	600 Travis Street
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 5050
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77002
CY2023Q1	dei	City Area Code CityAreaCode	(469)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	398-2200
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34807815	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	463475	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	100000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1571318	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	113676	usd
CY2022Q4	cenqu	Deferred Transaction Costs DeferredTransactionCosts	3258880	usd
CY2023Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	28847	usd
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	6277	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	36507980	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	3842308	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	258000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	258000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6834	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7414	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	268085	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	323170	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5432847	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1925151	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1925151	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	7890917	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2513735	usd
CY2023Q1	us-gaap	Assets Assets	44398897	usd
CY2022Q4	us-gaap	Assets Assets	6356043	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	242804	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2857223	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	995344	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	762119	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	182885	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	237970	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	188034	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	7444	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	11166	usd
CY2023Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	409279	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	312446	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2338236	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3868478	usd
CY2022Q4	cenqu	Contingent Consideration ContingentConsideration	1299000	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1587975	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	85200	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	85200	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5268768	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	6941943	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1384200	usd
CY2023Q1	us-gaap	Liabilities Liabilities	9280179	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5252678	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2022Q4	cenqu	Intermediate Members Equity IntermediateMembersEquity	12775902	usd
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	936	usd
CY2023Q1	dei	Entity File Number EntityFileNumber	001-40743
CY2023Q1	cenqu	Common Stock Value1 CommonStockValue1	2250	usd
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Verde Clean Fuels, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33924078	usd
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1863331
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	600 Travis Street
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21753603	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11672537	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	22945057	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35118718	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1103365	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44398897	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6356043	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4333465	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1328035	usd
CY2023Q1	cenqu	Contingent Consideration Amount ContingentConsiderationAmount	-1299000	usd
CY2023Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	82662	usd
CY2022Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	97242	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3117127	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1425277	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-3117127	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1425277	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2542666	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-574461	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1425277	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1103365	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1103365	usd
CY2023Q1	cenqu	Reversal Of Bcifh Original Equity ReversalOfBCIFHOriginalEquity	-1103365	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	36089053	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2146792	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3117127	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35118718	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6786461	usd
CY2022Q1	cenqu	Capital Contribution CapitalContribution	1250000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	602498	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1425277	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6359240	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3117127	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1425277	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-1299000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	580	usd
CY2022Q1	us-gaap	Depreciation Depreciation	2714	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2146792	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	602498	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	36463	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1457643	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1433	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	51810	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	91493	usd
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 5050
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77002
CY2023Q1	dei	City Area Code CityAreaCode	(469)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	398-2200
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34807815	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	463475	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	100000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1571318	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	113676	usd
CY2022Q4	cenqu	Deferred Transaction Costs DeferredTransactionCosts	3258880	usd
CY2023Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	28847	usd
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	6277	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	36507980	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	3842308	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	258000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	258000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6834	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7414	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	268085	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	323170	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5432847	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1925151	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1925151	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	7890917	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2513735	usd
CY2023Q1	us-gaap	Assets Assets	44398897	usd
CY2022Q4	us-gaap	Assets Assets	6356043	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	242804	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2857223	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	995344	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	762119	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	182885	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	237970	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	188034	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	7444	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	11166	usd
CY2023Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	409279	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	312446	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2338236	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3868478	usd
CY2022Q4	cenqu	Contingent Consideration ContingentConsideration	1299000	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1587975	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	85200	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	85200	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5268768	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	6941943	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1384200	usd
CY2023Q1	us-gaap	Liabilities Liabilities	9280179	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5252678	usd
CY2022Q4	cenqu	Intermediate Members Equity IntermediateMembersEquity	12775902	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	936	usd
CY2023Q1	cenqu	Common Stock Value1 CommonStockValue1	2250	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33924078	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21753603	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11672537	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	22945057	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35118718	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1103365	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44398897	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6356043	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4333465	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1328035	usd
CY2023Q1	cenqu	Contingent Consideration Amount ContingentConsiderationAmount	-1299000	usd
CY2023Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	82662	usd
CY2022Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	97242	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3117127	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1425277	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-3117127	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1425277	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2542666	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-574461	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1425277	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1103365	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1103365	usd
CY2023Q1	cenqu	Reversal Of Bcifh Original Equity ReversalOfBCIFHOriginalEquity	-1103365	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	36089053	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2146792	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3117127	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35118718	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	792085	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-45898	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2846040	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-775903	usd
CY2023Q1	cenqu	Pipe Proceeds PIPEProceeds	32000000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	19031516	usd
CY2023Q1	cenqu	Less Transaction Expenses LessTransactionExpenses	10043793	usd
CY2023Q1	cenqu	Bcf Holdings Capital Repayment BCFHoldingsCapitalRepayment	3750000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	3719	usd
CY2022Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	3069	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	12508	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	22570	usd
CY2022Q1	cenqu	Capital Contribution CapitalContribution	1250000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37198926	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1246931	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	34352886	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	471028	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	463475	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	87638	usd
CY2023Q1	cenqu	Cenaq Operating Cash Balance Acquired CENAQOperatingCashBalanceAcquired	91454	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34907815	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	558666	usd
CY2023Q1	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	312446	usd
CY2023Q1	cenqu	Noncash Impact Of Debt Issuance Through The Business Combination NoncashImpactOfDebtIssuanceThroughTheBusinessCombination	409279	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6786461	usd
CY2022Q1	cenqu	Capital Contribution CapitalContribution	1250000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	602498	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1425277	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6359240	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Such estimates may be subject to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b> </b></p>
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	100000	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. As of March 31, 2023, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b> </b></p>
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3117127	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1425277	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-1299000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	580	usd
CY2022Q1	us-gaap	Depreciation Depreciation	2714	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2146792	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	602498	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	36463	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1457643	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1433	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	51810	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	91493	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	792085	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-45898	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2846040	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-775903	usd
CY2023Q1	cenqu	Pipe Proceeds PIPEProceeds	32000000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	19031516	usd
CY2023Q1	cenqu	Less Transaction Expenses LessTransactionExpenses	10043793	usd
CY2023Q1	cenqu	Bcf Holdings Capital Repayment BCFHoldingsCapitalRepayment	3750000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	3719	usd
CY2022Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	3069	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	12508	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	22570	usd
CY2022Q1	cenqu	Capital Contribution CapitalContribution	1250000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37198926	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1246931	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	34352886	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	471028	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	463475	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	87638	usd
CY2023Q1	cenqu	Cenaq Operating Cash Balance Acquired CENAQOperatingCashBalanceAcquired	91454	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34907815	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	558666	usd
CY2023Q1	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	312446	usd
CY2023Q1	cenqu	Noncash Impact Of Debt Issuance Through The Business Combination NoncashImpactOfDebtIssuanceThroughTheBusinessCombination	409279	usd
CY2023Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	96738	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	86120	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	418261	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	558860	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	416797	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	107022	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	63548	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10117	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	995344	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	762119	usd
CY2023Q1	cenqu	Gross Amount GrossAmount	1925151	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1925151	usd
CY2023Q1	cenqu	Percentage Of Receive percentageOfReceive	0.10	pure
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2146792	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1299000	usd
CY2023Q1	srt	Financing Receivable Nonaccrual To Outstanding Percent FinancingReceivableNonaccrualToOutstandingPercent	1	pure
CY2023Q1	us-gaap	Business Combination Acquired Receivables Description BusinessCombinationAcquiredReceivablesDescription	The Business Combination includes: ●Holdings contributing 100% of the issued and outstanding limited liability company interests of Intermediate to OpCo in exchange for 22,500,000 Class C OpCo Units and an equal number of shares of Class C common stock; ● The issuance and sale of 3,200,000 shares of Class A common stock for a purchase price of $10.00 per share, for an aggregate purchase price of $32,000,000 in the PIPE Financing pursuant to the Subscription Agreements; ●Delivery of $19,031,516 of proceeds from CENAQ’s Trust Account related to non-redeeming Holders of 1,846,120 of Class A common stock; and ●Repayment of $3,750,000 of capital contributions made by Holdings since December 2021 and payment of $10,043,793 of transaction expenses including deferred underwriting fees of $1,700,000
CY2023Q1	us-gaap	Other Ownership Interests Units Issued OtherOwnershipInterestsUnitsIssued	31858620	shares
CY2023Q1	cenqu	Total Shares Of Common Stock At Closing Shares TotalSharesOfCommonStockAtClosingShares	31858620	shares
CY2023Q1	cenqu	Total Shares Of Common Stock At Closing Percentage Of Common Stock TotalSharesOfCommonStockAtClosingPercentageOfCommonStock	1	pure
CY2023Q1	cenqu	Total Diluted Shares At Closingincluding Shares Above Share TotalDilutedSharesAtClosingincludingSharesAboveShare	35358620	shares
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	91454	usd
CY2023Q1	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	3750000	usd
CY2023Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	184612	usd
CY2023Q1	us-gaap	Other Notes Payable OtherNotesPayable	409612	usd
CY2023Q1	us-gaap	Interest Expense Trust Preferred Securities InterestExpenseTrustPreferredSecurities	3500000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Such estimates may be subject to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b> </b></p>
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	100000	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. As of March 31, 2023, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b> </b></p>
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	762119	usd
CY2023Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	96738	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	86120	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	418261	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	558860	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	416797	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	107022	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	63548	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10117	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	995344	usd
CY2022Q4	us-gaap	Business Combination Control Obtained Description BusinessCombinationControlObtainedDescription	the Company entered into a 25-year land lease in Maricopa, Arizona with the intent of building a biofuel processing facility. The commencement date of the lease is in February of 2023 as control of the identified asset did not transfer to the Company on the effective date of the lease. As such, the Company did not record a ROU asset nor a lease liability as of December 31, 2022, specific to the land lease. Construction of the facility is expected to commence in fiscal year 2024 and the Company expects to incur an asset retirement obligation throughout the construction period as the Company is obligated to return the land to its original state upon exit of the lease. The fair value of the asset retirement obligation is zero as of March 31, 2023 and December 31, 2022, as construction has not commenced. The present value of the minimum lease payments exceeds the fair value of the land, and, accordingly, the lease is classified as a finance lease under ASC 842. The lease expires in 2047 and contains a single four-year renewal option. The exercise of the lease renewal is at the Company’s discretion; however, management is not reasonably expected to exercise the option; thus, the option is not included within the lease term. Renewal periods are included in the expected lease term only if they are reasonably certain of being exercised by the Company.
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	36462	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	67825	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	104287	usd
CY2023Q1	us-gaap	Operating Leases Income Statement Initial Direct Costs OperatingLeasesIncomeStatementInitialDirectCosts	60179	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	35146	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	199613	usd
CY2022Q1	us-gaap	Operating Leases Income Statement Initial Direct Costs OperatingLeasesIncomeStatementInitialDirectCosts	58030	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	38947	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	96977	usd
CY2023Q1	cenqu	Gross Amount GrossAmount	1925151	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1925151	usd
CY2023Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	11461	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	11461	usd
CY2022Q1	cenqu	Less Transaction Expenses LessTransactionExpenses		usd
CY2023Q1	cenqu	Percentage Of Receive percentageOfReceive	0.10	pure
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2146792	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1299000	usd
CY2023Q1	srt	Financing Receivable Nonaccrual To Outstanding Percent FinancingReceivableNonaccrualToOutstandingPercent	1	pure
CY2023Q1	us-gaap	Business Combination Acquired Receivables Description BusinessCombinationAcquiredReceivablesDescription	The Business Combination includes: ●Holdings contributing 100% of the issued and outstanding limited liability company interests of Intermediate to OpCo in exchange for 22,500,000 Class C OpCo Units and an equal number of shares of Class C common stock; ● The issuance and sale of 3,200,000 shares of Class A common stock for a purchase price of $10.00 per share, for an aggregate purchase price of $32,000,000 in the PIPE Financing pursuant to the Subscription Agreements; ●Delivery of $19,031,516 of proceeds from CENAQ’s Trust Account related to non-redeeming Holders of 1,846,120 of Class A common stock; and ●Repayment of $3,750,000 of capital contributions made by Holdings since December 2021 and payment of $10,043,793 of transaction expenses including deferred underwriting fees of $1,700,000
CY2023Q1	us-gaap	Other Ownership Interests Units Issued OtherOwnershipInterestsUnitsIssued	31858620	shares
CY2023Q1	cenqu	Total Shares Of Common Stock At Closing Shares TotalSharesOfCommonStockAtClosingShares	31858620	shares
CY2023Q1	cenqu	Total Shares Of Common Stock At Closing Percentage Of Common Stock TotalSharesOfCommonStockAtClosingPercentageOfCommonStock	1	pure
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	91454	usd
CY2023Q1	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	3750000	usd
CY2023Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1914	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1914	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	36048	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	36048	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49423	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49423	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	42589	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	42009	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6834	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7414	usd
CY2023Q1	us-gaap	Depreciation Depreciation	580	usd
CY2022Q1	us-gaap	Depreciation Depreciation	2714	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	15
CY2023Q1	cenqu	Earnout Consideration Vested Price EarnoutConsiderationVestedPrice	18
CY2023Q1	cenqu	Earnout Consideration Share Price EarnoutConsiderationSharePrice	15
CY2023Q1	cenqu	Measurement Share Price MeasurementSharePrice	18
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	10594000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y10M17D
CY2023Q1	cenqu	Compound Annual Growth Rate CompoundAnnualGrowthRate	0.047	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.147	pure
CY2023Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1000	shares
CY2023Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1000	shares
CY2020Q3	us-gaap	Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage	0.25	pure
CY2023Q1	cenqu	Incentive Units Granted IncentiveUnitsGranted	There were 800 Series A Incentive Units granted by Holdings in August of 2020 and 600 and 400 were unvested as of December 31, 2021 and 2022, respectively. As the award recipients resided on subsidiaries of Intermediate and provided service to the Company, the Company recognized $602,498 of compensation expense related to the awards during the three months ended March 31, 2022.
CY2022Q4	us-gaap	Shares Issued SharesIssued	1000	shares
CY2020Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1000	shares
CY2022Q3	cenqu	Percentage Of Founders PercentageOfFounders	0.10	pure
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.20	pure
CY2023Q1	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	The Business Combination was structured as a reverse merger and recapitalization which results in a common control arrangement where Holdings, the party that controls the reporting entity prior to the Business Combination, continues to control the Company immediately after the Business Combination.
CY2023Q1	us-gaap	Common Stocks Including Additional Paid In Capital Net Of Discount CommonStocksIncludingAdditionalPaidInCapitalNetOfDiscount	3509	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	15412479	usd
CY2023Q1	cenqu	Public Warrants PublicWarrants	12937479	shares
CY2023Q1	us-gaap	Payments For Repurchase Of Private Placement PaymentsForRepurchaseOfPrivatePlacement	2475000	usd
CY2023Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	184612	usd
CY2023Q1	us-gaap	Other Notes Payable OtherNotesPayable	409612	usd
CY2023Q1	us-gaap	Interest Expense Trust Preferred Securities InterestExpenseTrustPreferredSecurities	3500000	usd
CY2022Q4	us-gaap	Business Combination Control Obtained Description BusinessCombinationControlObtainedDescription	the Company entered into a 25-year land lease in Maricopa, Arizona with the intent of building a biofuel processing facility. The commencement date of the lease is in February of 2023 as control of the identified asset did not transfer to the Company on the effective date of the lease. As such, the Company did not record a ROU asset nor a lease liability as of December 31, 2022, specific to the land lease. Construction of the facility is expected to commence in fiscal year 2024 and the Company expects to incur an asset retirement obligation throughout the construction period as the Company is obligated to return the land to its original state upon exit of the lease. The fair value of the asset retirement obligation is zero as of March 31, 2023 and December 31, 2022, as construction has not commenced. The present value of the minimum lease payments exceeds the fair value of the land, and, accordingly, the lease is classified as a finance lease under ASC 842. The lease expires in 2047 and contains a single four-year renewal option. The exercise of the lease renewal is at the Company’s discretion; however, management is not reasonably expected to exercise the option; thus, the option is not included within the lease term. Renewal periods are included in the expected lease term only if they are reasonably certain of being exercised by the Company.
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	36462	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	67825	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	104287	usd
CY2023Q1	us-gaap	Operating Leases Income Statement Initial Direct Costs OperatingLeasesIncomeStatementInitialDirectCosts	60179	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	35146	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	199613	usd
CY2022Q1	us-gaap	Operating Leases Income Statement Initial Direct Costs OperatingLeasesIncomeStatementInitialDirectCosts	58030	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	38947	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	96977	usd
CY2023Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	11461	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	11461	usd
CY2023Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1914	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1914	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	36048	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	36048	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49423	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49423	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	42589	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	42009	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6834	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7414	usd
CY2023Q1	us-gaap	Depreciation Depreciation	580	usd
CY2022Q1	us-gaap	Depreciation Depreciation	2714	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	15
CY2023Q1	cenqu	Earnout Consideration Vested Price EarnoutConsiderationVestedPrice	18
CY2023Q1	cenqu	Earnout Consideration Share Price EarnoutConsiderationSharePrice	15
CY2023Q1	cenqu	Measurement Share Price MeasurementSharePrice	18
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	10594000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50	pure
CY2022Q1	cenqu	Bcf Holdings Capital Repayment BCFHoldingsCapitalRepayment		usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2023Q1	cenqu	Capital Contribution CapitalContribution		usd
CY2023Q1	us-gaap	Ownshare Lending Arrangement Shares Issued OwnshareLendingArrangementSharesIssued	1	shares
CY2023Q1	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.01
CY2023Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	18
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0	pure
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	312446	usd
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	8240626	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	195311	usd
CY2023Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	119186	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	49145	usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	8365896	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8365896	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q1	us-gaap	Contract Termination Claims Us Federal Government ContractTerminationClaimsUSFederalGovernment	234026	usd
CY2022Q4	us-gaap	Contract Termination Claims Us Federal Government ContractTerminationClaimsUSFederalGovernment	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.056	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.0263	pure
CY2023Q1	cenqu	Deferred Tax Impact Of Acquisition Of Bluescapein Dollars DeferredTaxImpactOfAcquisitionOfBluescapeinDollars	12.3165	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-12.4442	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.21	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.85	pure
CY2023Q1	cenqu	Net Cash Saving Percentage NetCashSavingPercentage	0.15	pure
CY2023Q1	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	50000000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y10M17D
CY2023Q1	cenqu	Compound Annual Growth Rate CompoundAnnualGrowthRate	0.047	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.147	pure
CY2023Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1000	shares
CY2023Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1000	shares
CY2020Q3	us-gaap	Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage	0.25	pure
CY2023Q1	cenqu	Incentive Units Granted IncentiveUnitsGranted	There were 800 Series A Incentive Units granted by Holdings in August of 2020 and 600 and 400 were unvested as of December 31, 2021 and 2022, respectively. As the award recipients resided on subsidiaries of Intermediate and provided service to the Company, the Company recognized $602,498 of compensation expense related to the awards during the three months ended March 31, 2022.
CY2022Q4	us-gaap	Shares Issued SharesIssued	1000	shares
CY2020Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1000	shares
CY2022Q3	cenqu	Percentage Of Founders PercentageOfFounders	0.10	pure
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.20	pure
CY2023Q1	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	The Business Combination was structured as a reverse merger and recapitalization which results in a common control arrangement where Holdings, the party that controls the reporting entity prior to the Business Combination, continues to control the Company immediately after the Business Combination.
CY2023Q1	us-gaap	Common Stocks Including Additional Paid In Capital Net Of Discount CommonStocksIncludingAdditionalPaidInCapitalNetOfDiscount	3509	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	15412479	usd
CY2023Q1	cenqu	Public Warrants PublicWarrants	12937479	shares
CY2023Q1	us-gaap	Payments For Repurchase Of Private Placement PaymentsForRepurchaseOfPrivatePlacement	2475000	usd
CY2023Q1	us-gaap	Ownshare Lending Arrangement Shares Issued OwnshareLendingArrangementSharesIssued	1	shares
CY2023Q1	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.01
CY2023Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	18
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0	pure
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	312446	usd
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	8240626	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	195311	usd
CY2023Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	119186	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	49145	usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	8365896	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8365896	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q1	us-gaap	Contract Termination Claims Us Federal Government ContractTerminationClaimsUSFederalGovernment	234026	usd
CY2022Q4	us-gaap	Contract Termination Claims Us Federal Government ContractTerminationClaimsUSFederalGovernment	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2022Q1	cenqu	Cenaq Operating Cash Balance Acquired CENAQOperatingCashBalanceAcquired		usd
CY2022Q4	cenqu	Common Stock Value1 CommonStockValue1		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.056	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.0263	pure
CY2023Q1	cenqu	Deferred Tax Impact Of Acquisition Of Bluescapein Dollars DeferredTaxImpactOfAcquisitionOfBluescapeinDollars	12.3165	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-12.4442	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.21	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.85	pure
CY2023Q1	cenqu	Net Cash Saving Percentage NetCashSavingPercentage	0.15	pure
CY2023Q1	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	50000000	usd
CY2023Q1	us-gaap	Net Income Loss Allocated To Limited Partners NetIncomeLossAllocatedToLimitedPartners	-574461	usd
CY2023Q1	us-gaap	Weighted Average Basic Shares Outstanding Pro Forma WeightedAverageBasicSharesOutstandingProForma	6124245	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6124245	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted Pro Forma Adjustment EarningsPerShareDilutedProFormaAdjustment	-0.09
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2023Q1	cenqu	Total Antidilutive Instruments TotalAntidilutiveInstruments	18687817	shares
CY2023Q1	cenqu	Antidilutive Common Shares AntidilutiveCommonShares	18687817	shares
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023Q1	cenqu	Intermediate Members Equity IntermediateMembersEquity		usd
CY2023Q1	us-gaap	Net Income Loss Allocated To Limited Partners NetIncomeLossAllocatedToLimitedPartners	-574461	usd
CY2023Q1	us-gaap	Weighted Average Basic Shares Outstanding Pro Forma WeightedAverageBasicSharesOutstandingProForma	6124245	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6124245	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted Pro Forma Adjustment EarningsPerShareDilutedProFormaAdjustment	-0.09
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2023Q1	cenqu	Total Antidilutive Instruments TotalAntidilutiveInstruments	18687817	shares
CY2023Q1	cenqu	Antidilutive Common Shares AntidilutiveCommonShares	18687817	shares
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023Q1	cenqu	Intermediate Members Equity IntermediateMembersEquity		usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q4	cenqu	Common Stock Value1 CommonStockValue1		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2022Q1	cenqu	Contingent Consideration Amount ContingentConsiderationAmount		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q1	cenqu	Class A Sponsor Earn Out Shares ClassASponsorEarnOutShares		usd
CY2023Q1	cenqu	Class C Sponsor Earn Out Shares ClassCSponsorEarnOutShares		usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2023Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment		usd
CY2022Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q1	cenqu	Pipe Proceeds PIPEProceeds		usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2022Q1	cenqu	Less Transaction Expenses LessTransactionExpenses		usd
CY2022Q1	cenqu	Bcf Holdings Capital Repayment BCFHoldingsCapitalRepayment		usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2023Q1	cenqu	Capital Contribution CapitalContribution		usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q1	cenqu	Class A Sponsor Earn Out Shares ClassASponsorEarnOutShares		usd
CY2023Q1	cenqu	Class C Sponsor Earn Out Shares ClassCSponsorEarnOutShares		usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2023Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment		usd
CY2022Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q1	cenqu	Pipe Proceeds PIPEProceeds		usd
CY2022Q1	cenqu	Cenaq Operating Cash Balance Acquired CENAQOperatingCashBalanceAcquired		usd
CY2022Q1	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds		usd
CY2022Q1	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds		usd
CY2022Q1	cenqu	Noncash Impact Of Debt Issuance Through The Business Combination NoncashImpactOfDebtIssuanceThroughTheBusinessCombination		usd
CY2022Q1	cenqu	Noncash Impact Of Debt Issuance Through The Business Combination NoncashImpactOfDebtIssuanceThroughTheBusinessCombination		usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross		usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross		usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense		pure
CY2022	cenqu	Deferred Tax Impact Of Acquisition Of Bluescapein Dollars DeferredTaxImpactOfAcquisitionOfBluescapeinDollars		pure
CY2022	cenqu	Deferred Tax Impact Of Acquisition Of Bluescapein Dollars DeferredTaxImpactOfAcquisitionOfBluescapeinDollars		pure
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount		shares
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001841425
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount		shares
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001841425

Files In Submission

Name	View Source	Status
0001213900-23-040105-index-headers.html	Edgar Link	pending
0001213900-23-040105-index.html	Edgar Link	pending
0001213900-23-040105.txt	Edgar Link	pending
0001213900-23-040105-xbrl.zip	Edgar Link	pending
cenqu-20230331.xsd	Edgar Link	pending
f10q0323ex31-1_verdeclean.htm	Edgar Link	pending
f10q0323ex31-2_verdeclean.htm	Edgar Link	pending
f10q0323ex32-1_verdeclean.htm	Edgar Link	pending
f10q0323ex32-2_verdeclean.htm	Edgar Link	pending
f10q0323_verdeclean.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
cenqu-20230331_cal.xml	Edgar Link	unprocessable
cenqu-20230331_lab.xml	Edgar Link	unprocessable
cenqu-20230331_def.xml	Edgar Link	unprocessable
cenqu-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0323_verdeclean_htm.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VGAS
Verde Clean Fuels Inc Stock $vgas

2023 Q1 Form 10-Q Financial Statement

#000121390023040105 Filed on May 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VGAS Verde Clean Fuels Inc Stock $vgas

2023 Q1 Form 10-Q Financial Statement

#000121390023040105 Filed on May 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VGAS
Verde Clean Fuels Inc Stock $vgas